The Role of Mesenchymal Stromal Cells and Their Products in the Treatment of Injured Spinal Cords
暂无分享,去创建一个
[1] N. Baldini,et al. Intra-individual variability in the neuroprotective and promyelinating properties of conditioned culture medium obtained from human adipose mesenchymal stromal cells , 2023, Stem Cell Research & Therapy.
[2] Cheng Wang,et al. A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication , 2023, Cell Communication and Signaling.
[3] A. Awidi,et al. Safe Reversal of Motor and Sensory Deficits by Repeated High Doses of Mesenchymal Stem Cells in a Patient with Chronic Complete Spinal Cord Injury , 2023, The American journal of case reports.
[4] K. So,et al. Intranasal delivery of BDNF-loaded small extracellular vesicles for cerebral ischemia therapy. , 2023, Journal of controlled release : official journal of the Controlled Release Society.
[5] Wenwei Jiang,et al. Exosomes combined with biomaterials in the treatment of spinal cord injury , 2023, Frontiers in Bioengineering and Biotechnology.
[6] Y. Liu,et al. Three-dimensional-cultured MSC-derived exosome with hydrogel for cerebral ischemia repair. , 2023, Biomaterials advances.
[7] M. Shekh,et al. Exosomes and Their Bioengineering Strategies in the Cutaneous Wound Healing and Related Complications: Current Knowledge and Future Perspectives , 2023, International journal of biological sciences.
[8] L. Slovinská,et al. Characterisation of mesenchymal stem cells conditioned media obtained at different conditioning times: their effect on glial cells in in vitro scratch model , 2023, Growth factors.
[9] Xiaoli Tian,et al. Microglial depletion impairs glial scar formation and aggravates inflammation partly by inhibiting STAT3 phosphorylation in astrocytes after spinal cord injury , 2022, Neural regeneration research.
[10] Kexin Chen,et al. Recent Advances in Cell and Functional Biomaterial Treatment for Spinal Cord Injury , 2022, BioMed research international.
[11] G. Sukhikh,et al. Human Multipotent Mesenchymal Stromal Cell–Derived Extracellular Vesicles Enhance Neuroregeneration in a Rat Model of Sciatic Nerve Crush Injury , 2022, International journal of molecular sciences.
[12] Hengxing Zhou,et al. Autologous exosome facilitates load and target delivery of bioactive peptides to repair spinal cord injury. , 2022, Bioactive materials.
[13] E. Mazzon,et al. Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury? , 2022, International journal of molecular sciences.
[14] L. Dargahi,et al. Hippocampal neuroprotection mediated by secretome of human mesenchymal stem cells against experimental stroke , 2022, CNS neuroscience & therapeutics.
[15] J. Kocsis,et al. Enhanced Network in Corticospinal Tracts after Infused Mesenchymal Stem Cells in Spinal Cord Injury , 2022, Journal of neurotrauma.
[16] M. Misra,et al. Safety and feasibility of intramedullary injected bone marrow-derived mesenchymal stem cells in acute complete spinal cord injury: phase 1 trial. , 2022, Journal of neurosurgery. Spine.
[17] E. Candi,et al. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases , 2022, Signal Transduction and Targeted Therapy.
[18] M. Seo,et al. Human Epidural AD–MSC Exosomes Improve Function Recovery after Spinal Cord Injury in Rats , 2022, Biomedicines.
[19] Y. Higami,et al. Intravenous administration of human mesenchymal stem cells derived from adipose tissue and umbilical cord improves neuropathic pain via suppression of neuronal damage and anti-inflammatory actions in rats , 2022, PloS one.
[20] L. Slovinská,et al. Mesenchymal Stem Cells in the Treatment of Human Spinal Cord Injury: The Effect on Individual Values of pNF-H, GFAP, S100 Proteins and Selected Growth Factors, Cytokines and Chemokines , 2022, Current issues in molecular biology.
[21] L. Rong,et al. Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury , 2022, Neural regeneration research.
[22] M. V. Kiselevskii,et al. Secretome of Mesenchymal Bone Marrow Stem Cells: Is It Immunosuppressive or Proinflammatory? , 2021, Bulletin of Experimental Biology and Medicine.
[23] Chenghai Li,et al. Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice , 2021, Cell & bioscience.
[24] A. Nógrádi,et al. Stem Cell Secretome for Spinal Cord Repair: Is It More than Just a Random Baseline Set of Factors? , 2021, Cells.
[25] Hyo Jeong Kim,et al. Brain-Derived Neurotrophic Factor Secreting Human Mesenchymal Stem Cells Improve Outcomes in Rett Syndrome Mouse Models , 2021, Frontiers in Neuroscience.
[26] D. Salzig,et al. Scaled preparation of extracellular vesicles from conditioned media. , 2021, Advanced drug delivery reviews.
[27] Z. Suo,et al. Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine , 2021, Cells.
[28] Qiuli Liu,et al. Mesenchymal Stem Cell-Macrophage Crosstalk and Maintenance of Inflammatory Microenvironment Homeostasis , 2021, Frontiers in Cell and Developmental Biology.
[29] F. Djouad,et al. The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming , 2021, Frontiers in Immunology.
[30] M. Farhoudi,et al. Design of graphenic nanocomposites containing chitosan and polyethylene glycol for spinal cord injury improvement , 2021, RSC advances.
[31] J. Silver,et al. New insights into glial scar formation after spinal cord injury , 2021, Cell and Tissue Research.
[32] L. Lossi,et al. Mesenchymal stem cell conditioned medium increases glial reactivity and decreases neuronal survival in spinal cord slice cultures , 2021, Biochemistry and biophysics reports.
[33] G. Terstappen,et al. Strategies for delivering therapeutics across the blood–brain barrier , 2021, Nature Reviews Drug Discovery.
[34] R. Rennert,et al. Review of operative considerations in spinal cord stem cell therapy , 2021, World journal of stem cells.
[35] X. Sui,et al. Nerve growth factor (NGF) and NGF receptors in mesenchymal stem/stromal cells: Impact on potential therapies , 2021, Stem cells translational medicine.
[36] X. Kang,et al. Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury , 2021, Stem Cell Research & Therapy.
[37] B. Liu,et al. Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study. , 2020, Cytotherapy.
[38] J. Benito-Penalva,et al. Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study. , 2020, Cytotherapy.
[39] Q. H. Looi,et al. Treatment of spinal cord injury with mesenchymal stem cells , 2020, Cell & bioscience.
[40] J. Innes,et al. An In Vitro Comparison of the Neurotrophic and Angiogenic Activity of Human and Canine Adipose-Derived Mesenchymal Stem Cells (MSCs): Translating MSC-Based Therapies for Spinal Cord Injury , 2020, Biomolecules.
[41] J. Phillips,et al. Cell Therapies for Spinal Cord Injury: Trends and Challenges of Current Clinical Trials. , 2020, Neurosurgery.
[42] W. Banks,et al. Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation , 2020, International journal of molecular sciences.
[43] S. Mousavi,et al. Umbilical cord-derived mesenchymal stem cells in neurodegenerative disorders: from literature to clinical practice. , 2020, Regenerative medicine.
[44] Y. Niu,et al. The role of hepatocyte growth factor in mesenchymal stem cell-induced recovery in spinal cord injured rats , 2020, Stem Cell Research & Therapy.
[45] Jianqing Gao,et al. Transplantation of Human Mesenchymal Stem Cell-Derived Exosomes Immobilized in An Adhesive Hydrogel for Effective Treatment of Spinal Cord Injury. , 2020, Nano letters.
[46] Ling-ling Wu,et al. Repairing and Analgesic Effects of Umbilical Cord Mesenchymal Stem Cell Transplantation in Mice with Spinal Cord Injury , 2020, BioMed research international.
[47] Shusen Cui,et al. Dissecting the Dual Role of the Glial Scar and Scar-Forming Astrocytes in Spinal Cord Injury , 2020, Frontiers in Cellular Neuroscience.
[48] Raghu Kalluri,et al. The biology, function, and biomedical applications of exosomes , 2020, Science.
[49] I. Martin,et al. Mesenchymal stem versus stromal cells: International Society for Cellular Therapy Mesenchymal Stromal Cell committee position statement on nomenclature. , 2019, Cytotherapy.
[50] Y. Kusnadi,et al. Motoric Recovery After Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Chronic Spinal Cord Injury: A Case Report. , 2019, The American journal of case reports.
[51] A. Hoffmann,et al. BDNF‐overexpressing human mesenchymal stem cells mediate increased neuronal protection in vitro , 2019, Journal of neuroscience research.
[52] M. Gimona,et al. Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing. , 2019, Cytotherapy.
[53] A. Vercelli,et al. Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy , 2019, International journal of molecular sciences.
[54] Zhifeng Xiao,et al. Different functional bio-scaffolds share similar neurological mechanism to promote locomotor recovery of canines with complete spinal cord injury. , 2019, Biomaterials.
[55] C. Tonda-Turo,et al. Chitosan-based hydrogel to support the paracrine activity of mesenchymal stem cells in spinal cord injury treatment , 2019, Scientific Reports.
[56] Jianghua Chen,et al. Genetic communication by extracellular vesicles is an important mechanism underlying stem cell-based therapy-mediated protection against acute kidney injury , 2019, Stem Cell Research & Therapy.
[57] M. Cifuentes,et al. Comparative analysis and characterization of soluble factors and exosomes from cultured adipose tissue and bone marrow mesenchymal stem cells in canine species. , 2019, Veterinary immunology and immunopathology.
[58] R. Berebichez-Fridman,et al. Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review. , 2018, Sultan Qaboos University medical journal.
[59] Changsheng Wang,et al. Neural differentiation of bone marrow mesenchymal stem cells with human brain‐derived neurotrophic factor gene‐modified in functionalized self‐assembling peptide hydrogel in vitro , 2018, Journal of cellular biochemistry.
[60] J. Innes,et al. Exposing mesenchymal stem cells to chondroitin sulphated proteoglycans reduces their angiogenic and neuro-adhesive paracrine activity. , 2018, Biochimie.
[61] Jing Xu,et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.
[62] M. Fehlings,et al. Human Oligodendrogenic Neural Progenitor Cells Delivered with Chondroitinase ABC Facilitate Functional Repair of Chronic Spinal Cord Injury , 2018, Stem cell reports.
[63] H. Noristani,et al. CSF1R Inhibition Reduces Microglia Proliferation, Promotes Tissue Preservation and Improves Motor Recovery After Spinal Cord Injury , 2018, Front. Cell. Neurosci..
[64] Yue Zhou,et al. Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury , 2018, Journal of neuroinflammation.
[65] J. Carballido,et al. Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline. , 2018, Cytotherapy.
[66] Sai Zhang,et al. Significant Improvement of Acute Complete Spinal Cord Injury Patients Diagnosed by a Combined Criteria Implanted with NeuroRegen Scaffolds and Mesenchymal Stem Cells , 2018, Cell transplantation.
[67] B. S. Ramalho,et al. Injection of bone marrow mesenchymal stem cells by intravenous or intraperitoneal routes is a viable alternative to spinal cord injury treatment in mice , 2018, Neural regeneration research.
[68] E. Ling,et al. Neurotrophin‐3 released from implant of tissue‐engineered fibroin scaffolds inhibits inflammation, enhances nerve fiber regeneration, and improves motor function in canine spinal cord injury , 2018, Journal of biomedical materials research. Part A.
[69] B. Yue,et al. Promotion of neurological recovery in rat spinal cord injury by mesenchymal stem cells loaded on nerve‐guided collagen scaffold through increasing alternatively activated macrophage polarization , 2018, Journal of tissue engineering and regenerative medicine.
[70] Yulin Li,et al. Rat vibrissa dermal papilla cells promote healing of spinal cord injury following transplantation , 2018, Experimental and therapeutic medicine.
[71] A. Spittler,et al. Isolation, cultivation, and characterization of human mesenchymal stem cells , 2018, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[72] V. Nogueira Silbiger,et al. Identification of new genes associated to senescent and tumorigenic phenotypes in mesenchymal stem cells , 2017, Scientific Reports.
[73] Wutian Wu,et al. Effect of VEGF on Inflammatory Regulation, Neural Survival, and Functional Improvement in Rats following a Complete Spinal Cord Transection , 2017, Front. Cell. Neurosci..
[74] Wu Jun Zhu He Yu Tian-fei Chen Gang. Progress of Stem Cell Therapy in Spinal Cord Injury , 2017 .
[75] Manoj Kumar,et al. INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.
[76] Wei Xu,et al. Mesenchymal Stem Cells Modulate Light-induced Activation of Retinal Microglia Through CX3CL1/CX3CR1 Signaling , 2016, Ocular immunology and inflammation.
[77] Pedro Quelhas,et al. Macrophage interactions with polylactic acid and chitosan scaffolds lead to improved recruitment of human mesenchymal stem/stromal cells: a comprehensive study with different immune cells , 2016, Journal of The Royal Society Interface.
[78] J. H. Park,et al. Comparative Efficacies of Long-Term Serial Transplantation of Syngeneic, Allogeneic, Xenogeneic, or CTLA4Ig-Overproducing Xenogeneic Adipose Tissue-Derived Mesenchymal Stem Cells on Murine Systemic Lupus Erythematosus , 2016, Cell transplantation.
[79] Q. Han,et al. Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a , 2016, Journal of Cell Science.
[80] M. Yousefifard,et al. Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model , 2016, Stem Cell Research & Therapy.
[81] D. Hu,et al. The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy , 2015, Stem Cell Research & Therapy.
[82] M. Rodríguez-Vázquez,et al. Chitosan and Its Potential Use as a Scaffold for Tissue Engineering in Regenerative Medicine , 2015, BioMed research international.
[83] I. Fournier,et al. Delivery of Alginate Scaffold Releasing Two Trophic Factors for Spinal Cord Injury Repair , 2015, Scientific Reports.
[84] Dingding Li,et al. VEGF inhibits the inflammation in spinal cord injury through activation of autophagy. , 2015, Biochemical and biophysical research communications.
[85] L. Ding,et al. Haploidentical hematopoietic stem cell transplant with umbilical cord-derived multipotent mesenchymal cell infusion for the treatment of high-risk acute leukemia in children , 2015, Leukemia & lymphoma.
[86] A. Salgado,et al. Secretome of Mesenchymal Progenitors from the Umbilical Cord Acts as Modulator of Neural/Glial Proliferation and Differentiation , 2014, Stem Cell Reviews and Reports.
[87] T. Yoshimine,et al. Intranasal delivery of bone marrow stromal cells to spinal cord lesions. , 2015, Journal of neurosurgery. Spine.
[88] Yu-ke Tian,et al. Anti-inflammatory Mechanism of Bone Marrow Mesenchymal Stem Cell Transplantation in Rat Model of Spinal Cord Injury , 2015, Cell Biochemistry and Biophysics.
[89] H. Okano,et al. Long-Term Safety Issues of iPSC-Based Cell Therapy in a Spinal Cord Injury Model: Oncogenic Transformation with Epithelial-Mesenchymal Transition , 2015, Stem cell reports.
[90] Yang-qiu Li,et al. Immunogenicity of allogeneic mesenchymal stem cells transplanted via different routes in diabetic rats , 2014, Cellular and Molecular Immunology.
[91] Š. Kubínová,et al. Human Mesenchymal Stem Cells Modulate Inflammatory Cytokines after Spinal Cord Injury in Rat , 2014, International journal of molecular sciences.
[92] H. Gabr,et al. Autologous Bone Marrow-Derived Cell Therapy Combined with Physical Therapy Induces Functional Improvement in Chronic Spinal Cord Injury Patients , 2014, Cell transplantation.
[93] J. Rubin,et al. Adipose stem cells: biology and clinical applications for tissue repair and regeneration. , 2014, Translational research : the journal of laboratory and clinical medicine.
[94] T. Yi,et al. Mesenchymal stem cells infected with Mycoplasma arginini secrete complement C3 to regulate immunoglobulin production in b lymphocytes , 2014, Cell Death and Disease.
[95] J. Karp,et al. Mesenchymal stem cells: immune evasive, not immune privileged , 2014, Nature Biotechnology.
[96] M. Griffin,et al. Autologous and allogeneic mesenchymal stem cells in organ transplantation: what do we know about their safety and efficacy? , 2014, Current opinion in organ transplantation.
[97] D. Yoo,et al. Neuroprotective Effects of Adipose-Derived Stem Cells Are Maintained for 3 Weeks against Ischemic Damage in the Rabbit Spinal Cord , 2014, BioMed research international.
[98] D. Howells,et al. Stem Cell Transplantation in Traumatic Spinal Cord Injury: A Systematic Review and Meta-Analysis of Animal Studies , 2013, PLoS biology.
[99] Y. Joe,et al. A ROCK Inhibitor Blocks the Inhibitory Effect of Chondroitin Sulfate Proteoglycan on Morphological Changes of Mesenchymal Stromal/Stem Cells into Neuron-Like Cells , 2013, Biomolecules & therapeutics.
[100] J. Chang,et al. Molecular Sciences Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell Therapy , 2022 .
[101] K. Tarte,et al. Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints. , 2013, Cytotherapy.
[102] K. Wood,et al. Mesenchymal stromal cells in transplantation rejection and tolerance. , 2013, Cold Spring Harbor perspectives in medicine.
[103] J. Leor,et al. Human Macrophage Regulation Via Interaction With Cardiac Adipose Tissue-Derived Mesenchymal Stromal Cells , 2013, Journal of cardiovascular pharmacology and therapeutics.
[104] Yi Li,et al. Exosome‐Mediated Transfer of miR‐133b from Multipotent Mesenchymal Stromal Cells to Neural Cells Contributes to Neurite Outgrowth , 2012, Stem cells.
[105] Arnold I Caplan,et al. Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models , 2012, Nature Neuroscience.
[106] H. Baba,et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. , 2012, Journal of neurotrauma.
[107] A. Gasbarrini,et al. Neurotrophic Features of Human Adipose Tissue-Derived Stromal Cells: In Vitro and In Vivo Studies , 2011, Journal of biomedicine & biotechnology.
[108] S. Lalwani,et al. Spinal cord injury. , 2011, Journal of neurosurgery. Spine.
[109] M. Stewart,et al. Mesenchymal stem cells: characteristics, sources, and mechanisms of action. , 2011, The Veterinary clinics of North America. Equine practice.
[110] S. Kang,et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. , 2011, Stem cells and development.
[111] H. Feng,et al. Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells , 2010, Critical care medicine.
[112] Y. Joe,et al. A Comparison of ROCK Inhibitors on Human Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Neuron-Like Cells , 2010 .
[113] Haisheng Peng,et al. In vitro differentiation of bone marrow stromal cells into neurons and glial cells and differential protein expression in a two-compartment bone marrow stromal cell/neuron co-culture system , 2010, Journal of Clinical Neuroscience.
[114] L F Geffner,et al. Administration of Autologous Bone Marrow Stem Cells into Spinal Cord Injury Patients via Multiple Routes is Safe and Improves their Quality of Life: Comprehensive Case Studies , 2008, Cell transplantation.
[115] Michael G Fehlings,et al. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. , 2008, Neurosurgical focus.
[116] U. Bogdahn,et al. The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. , 2006, Biomaterials.
[117] A. Asawachaicharn,et al. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis , 2006, Experimental Neurology.
[118] J. Zimmer,et al. Neural transdifferentiation of mesenchymal stem cells – a critical review , 2005, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[119] G. Moonen,et al. Plasticity of Cultured Mesenchymal Stem Cells: Switch from Nestin‐Positive to Excitable Neuron‐Like Phenotype , 2005, Stem cells.
[120] J. Shumsky,et al. Treatments for , 2004 .
[121] Christian Clausen,et al. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. , 2003, Bone.
[122] W. Janssen,et al. Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro , 2000, Experimental Neurology.
[123] R. Class,et al. Propagation and senescence of human marrow stromal cells in culture: a simple colony‐forming assay identifies samples with the greatest potential to propagate and differentiate , 1999, British journal of haematology.
[124] H. Winn,et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. , 1998, Journal of neurosurgery.
[125] E. Seifried,et al. Human mesenchymal stromal cells undergo apoptosis and fragmentation after intravenous application in immune-competent mice. , 2017, Cytotherapy.
[126] L. Slovinská,et al. Axonal outgrowth stimulation after alginate/mesenchymal stem cell therapy in injured rat spinal cord. , 2017, Acta neurobiologiae experimentalis.
[127] M. Pittenger,et al. Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects. , 2016, Transfusion medicine reviews.
[128] R. Henschler,et al. Fate of intravenously injected mesenchymal stem cells and significance for clinical application. , 2013, Advances in biochemical engineering/biotechnology.
[129] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.
[130] Qin-jun Zhao,et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. , 2006, Haematologica.
[131] J. Neuwirth,et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. , 2006, Cell transplantation.